1. "In Phase III clinical trials, two mRNA COVID-19 vaccines
    Joe PS3 Joe PS3 United States says:
    August 26, 2021 at 10:13 AM

    "In Phase III clinical trials, two mRNA COVID-19 vaccines (Pfizer/BioNTech's BNT162b2 and Moderna's mRNA-1273) were shown to be 94-95% effective in preventing symptomatic forms of the disease."

    How do they know this is true? This assumes that everyone who gets infected are symptomatic, which we already know is FAR from true.

    Reply
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback